QT
GTHX

Quantbot Technologies’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Quantbot Technologies’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,800
Closed -$38K – 2008
2024
Q1 		$38K Buy
+8,800
New +$30.7K ﹤0.01% 1359
2023
Q4 		– Sell
-6,800
Closed -$9.79K – 2077
2023
Q3 		$9.79K Sell
6,800
-8,400
-55% -$16.3K ﹤0.01% 1412
2023
Q2 		$37.8K Buy
15,200
+1,300
+9% +$3.55K ﹤0.01% 1355
2023
Q1 		$37.3K Sell
13,900
-15,331
-52% -$73.7K ﹤0.01% 1298
2022
Q4 		$159K Buy
29,231
+28,685
+5,254% +$240K 0.01% 986
2022
Q3 		$6K Sell
546
-25,741
-98% -$294K ﹤0.01% 1469
2022
Q2 		$129K Buy
+26,287
New +$146K 0.01% 1069
2022
Q1 		– Sell
-376
Closed -$3K – 2146
2021
Q4 		$3K Sell
376
-11,339
-97% -$144K ﹤0.01% 1414
2021
Q3 		$157K Buy
11,715
+11,499
+5,324% +$187K 0.01% 868
2021
Q2 		$4K Buy
+216
New +$4.8K ﹤0.01% 1381
2021
Q1 		– Sell
-720
Closed -$12K – 1836
2020
Q4 		$12K Sell
720
-155
-18% -$2.32K ﹤0.01% 1086
2020
Q3 		$10K Buy
+875
New +$14.4K ﹤0.01% 1121
2020
Q1 		– Sell
-5,950
Closed -$157K – 1489
2019
Q4 		$157K Buy
5,950
+3,872
+186% +$90.6K 0.02% 716
2019
Q3 		$47K Buy
+2,078
New +$65.5K ﹤0.01% 982
2018
Q4 		– Sell
-1,163
Closed -$60K – 1488
2018
Q3 		$60K Buy
1,163
+947
+438% +$51.6K ﹤0.01% 1010
2018
Q2 		$9K Sell
216
-1,674
-89% -$71.7K ﹤0.01% 1113
2018
Q1 		$70K Buy
+1,890
New +$50.4K 0.01% 931

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Quantbot Technologies's GTHX Position: Q2 2024 in Review

Quantbot Technologies sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2024, closing a stake of 8,800 shares — an estimated $38K sold.

Quantbot Technologies first reported a position in GTHX in Q1 2018 and held it in 17 quarters. The position peaked at $159K in Q4 2022. 88 funds tracked by Wall St. Rank hold GTHX as of Q2 2024.

  • Quantbot Technologies reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 8,800 G1 Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $38K.
  • Quantbot Technologies first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and held it in 17 quarters.
  • Quantbot Technologies's G1 Therapeutics, Inc. Common Stock position peaked at $159K in Q4 2022.
  • 88 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.